Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075501 · ClinicalTrials.gov registry record · Phase 4
Interactions Between Drug Effects and Environments II
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 133
- Enrollment target
NCT03075501 is a Phase 4 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 133 participants.
The verdict
NCT03075501, a Phase 4 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 133 participants
- Enrollment target
Study Summary
The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.
Interventions
- DRUG Placebo
- BEHAVIORAL Paired
- DRUG Stimulant or sedative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03075501
The ClinicalTrials.gov registry entry for NCT03075501 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03075501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03075501 about?
NCT03075501 is a clinical study titled "Interactions Between Drug Effects and Environments II". The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.
What is the current status of trial NCT03075501?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 133 participants. The study started on 2015-11. Estimated completion is 2020-07.
What interventions are being tested in trial NCT03075501?
The interventions under investigation include: Placebo (DRUG), Paired (BEHAVIORAL), Stimulant or sedative (DRUG).
Who is sponsoring clinical trial NCT03075501?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.